Innovative Technology Adoption AI Medical Service Inc. leverages advanced deep learning and AI technologies such as React, GSAP, and styled-components, demonstrating a strong technological foundation that can be attractive to partners seeking cutting-edge medical device and software collaborations.

Recognition and Awards Winning the METI Minister's Award and being named in Forbes Asia 100 To Watch 2024 positions the company as an innovative leader in medical AI, increasing its credibility and attractiveness as a potential client or partner in advanced healthcare solutions.

Expanding Global Presence Partnerships with institutions like Mahidol University and The Chinese University of Hong Kong highlight opportunities to offer joint research and licensing collaborations across Asia, opening pathways to international market expansion and co-developments.

Recent Market Entry The launch of their first AI software product for early stomach cancer detection indicates readiness for enterprise sales opportunities in hospitals and clinics focused on diagnostic tools, especially those interested in integrating AI diagnostics into their workflows.

Strong Funding Backing With substantial funding of 43 million USD from major investors including SoftBank Vision Fund 2, AI Medical Service Inc. is financially positioned to expand its product line, seek new strategic partnerships, and scale sales efforts to healthcare providers and medical device distributors.